• KAS-ATAC: Mapping Accessible ssDNA-Containing Genomes

  2026-10-05

  The 2025 Bio-protocol paper describes KAS-ATAC, an assay framework that identifies genomic fragments combining chromatin accessibility with single-stranded DNA features. Its main innovation is the integration of ATAC-seq-style accessibility profiling with N3-kethoxal-based ssDNA labeling, creating a readout for genomic regions where these signals coexist.

• SB-3CT and MMP9: Interpreting ECM Causality

  2026-10-05

  SB-3CT is a gelatinase inhibitor that helps frame how MMP-9 activity can be interpreted across extracellular-matrix models. This evidence-led analysis connects the 2026 Adamtsl3 study with tumor metastasis research and neurobiology while defining the boundaries of pharmacological inference.

• Dasatinib Monohydrate in Gastric Cancer Models

  2026-10-04

  Dasatinib Monohydrate, also known as BMS-354825, is primarily established in ABL- and SRC-related kinase research, particularly chronic myeloid leukemia and Philadelphia chromosome positive leukemia. A 2025 gastric cancer study showed that patient-derived assembloids containing matched tumor and stromal populations can produce drug responses that differ from organoid monocultures. This overview explains how that finding supports a conceptual research rationale for studying kinase-inhibitor sensitivity in tumor–stroma models, while emphasizing that the cited gastric cancer study does not establish a specific dasatinib response or clinical utility.

• B. fragilis and Gut-Brain Cholinergic Signaling

  2026-10-03

  Jia et al. identify a gut–vagus–brain cholinergic pathway through which Bacteroides fragilis suppresses seizures in mouse models, with associated Lactobacillus enrichment and supporting evidence from a pediatric clinical trial. The study advances microbiota research beyond association by combining microbial, neural-circuit, pharmacological, and clinical evidence, while leaving important questions about strain specificity, receptor mechanisms, and generalizability.

• AST 487 as a KDM4A Probe in Mesothelioma

  2026-10-01

  AST 487 offers a practical chemical-probe strategy for investigating KDM4A dependence in malignant pleural mesothelioma. This article translates the landmark KDM4A study into a rigorous workflow for chromatin, viability, apoptosis, DNA-repair, and combination assays.

• EdU Imaging Kits (HF594): Practical Workflow

  2026-10-01

  EdU Imaging Kits (HF594), SKU K2243, provide an endpoint method for measuring DNA synthesis during S phase by labeling incorporated 5-ethynyl-2’-deoxyuridine and detecting it with HyperFluor™ 594 azide click chemistry. The workflow is suited to fixed-cell fluorescence microscopy and flow cytometry, but not to live-cell real-time tracking or experiments in which copper-catalyzed reactions could interfere with the sample.

• TMEM16F Lipid Scrambling in Ferroptosis

  2026-09-30

  Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as an execution-stage suppressor of ferroptosis, distinct from intracellular antioxidant defenses. The study shows that disabling this membrane-remodeling response intensifies membrane collapse, increases danger signaling, slows tumor growth, and sensitizes tumors to PD-1 blockade.

• Lysosomal β-Galactosidase Staining Kit Guide

  2026-09-30

  Use X-gal chromogenic staining to visualize lysosomal acidic β-galactosidase in HNSCC cells and tissue sections, while avoiding the common error of treating blue signal as standalone proof of senescence. This workflow connects cisplatin-resistance research with reproducible controls, brightfield imaging, and orthogonal cellular senescence measurements.

• PBS (Phosphate-Buffered Saline) Workflow Guide

  2026-09-29

  PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, ready-to-use isotonic buffer for cell washing, reagent dilution, and other in vitro workflows requiring controlled pH and osmolarity. It is intended for scientific research only and should not replace complete cell culture medium or be used for diagnostic, clinical, or medical purposes.

• TaCRVP Hijacks Tomato Catalase to Suppress Defense

  2026-09-29

  A 2026 Advanced Science study identifies TaCRVP, a cysteine-rich venom protein in Tuta absoluta oral secretions, as an effector that redirects tomato redox regulation. By activating and stabilizing SlCAT2, TaCRVP suppresses hydrogen peroxide accumulation, downstream jasmonic acid signaling, and defensive metabolite production, revealing a mechanistic route by which a chewing herbivore manipulates host immunity.

• Preserving Phosphosignals in Metabolic Research

  2026-09-28

  A translational framework for protecting phosphorylation-dependent readouts in liver metabolism studies, using the SREBP-1c–CSE/H2S–ULK1 axis as a mechanistic case study and Phosphatase Inhibitor Cocktail 3 as a practical preanalytical control.

• ANGPTL3 sgRNA: A Multiplex Editing Strategy

  2026-09-28

  Explore how ANGPTL3 sgRNA targeting can support gene-function studies, and why a three-guide set is best treated as an experimental design opportunity rather than a guaranteed knockout. This guide connects multiplex CRISPR principles to practical decisions about editing, genotyping, and interpretation.

• Carvacrol as a TRPA1 Probe in Redox Assays

  2026-09-27

  Carvacrol (5-isopropyl-2-methylphenol) offers a useful, non-electrophilic TRPA1 agonist perspective for interpreting redox-sensitive channel assays. This article explains how ligand-selective responses to singlet oxygen can sharpen experimental design without overstating what the evidence shows.

• EZ Cap™ Cas9 mRNA (5-moUTP) for Fyn–Stat3 Studies

  2026-09-26

  Use EZ Cap™ Cas9 mRNA (5-moUTP) to build guide-directed loss-of-function tests around the Fyn–Stat3 neurodegeneration findings—without confusing gene editing with the study’s transgenic overexpression model. This workflow pairs careful RNA handling with dose, guide, and timing controls for interpretable functional gene studies.

• QX77 and the Next Questions in Autophagy Research

  2026-09-25

  QX77 offers a way to investigate LAMP2A and Rab11 regulation in chaperone-mediated autophagy. In the context of recent ETS1–SENP2–HSPA8–FUNDC1 findings in bronchopulmonary dysplasia, this article outlines how translational researchers can connect distinct autophagy mechanisms without conflating them—and design more informative experiments.

8481 records 1/566 page Next 12345 下5页 Last page